These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 21679851

  • 1. Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience.
    Adamson RM, Stahovich M, Chillcott S, Baradarian S, Chammas J, Jaski B, Hoagland P, Dembitsky W.
    J Am Coll Cardiol; 2011 Jun 21; 57(25):2487-95. PubMed ID: 21679851
    [Abstract] [Full Text] [Related]

  • 2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, Clayson SE, Reid BB, Moore SA, Blank DU, Renlund DG.
    J Thorac Cardiovasc Surg; 2008 Jun 21; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [Abstract] [Full Text] [Related]

  • 3. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.
    Ann Thorac Surg; 2008 Oct 21; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [Abstract] [Full Text] [Related]

  • 4. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.
    J Thorac Cardiovasc Surg; 2010 Jul 21; 140(1):174-81. PubMed ID: 20447659
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients.
    Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS, HeartMate II Investigators.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1826-34. PubMed ID: 20413033
    [Abstract] [Full Text] [Related]

  • 8. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era.
    Miller LW, Nelson KE, Bostic RR, Tong K, Slaughter MS, Long JW.
    J Heart Lung Transplant; 2006 Jul 27; 25(7):778-84. PubMed ID: 16818120
    [Abstract] [Full Text] [Related]

  • 9. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.
    Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928
    [Abstract] [Full Text] [Related]

  • 10. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH, HeartMate II Investigators.
    J Am Coll Cardiol; 2009 Jul 21; 54(4):312-21. PubMed ID: 19608028
    [Abstract] [Full Text] [Related]

  • 11. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D, REMATCH Investigators.
    Circulation; 2004 Aug 24; 110(8):975-81. PubMed ID: 15313942
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ.
    Circ Heart Fail; 2011 May 24; 4(3):266-75. PubMed ID: 21303989
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, Rose E, Holman W, Furukawa S, Frazier OH, Dembitsky W.
    J Thorac Cardiovasc Surg; 2005 Jan 24; 129(1):9-17. PubMed ID: 15632819
    [Abstract] [Full Text] [Related]

  • 14. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
    Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Miller LW, Deng M, Naka Y, Mancini D.
    Circ Heart Fail; 2009 Jan 24; 2(1):3-10. PubMed ID: 19808309
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes are similar in pulsatile and nonpulsatile left ventricular assist device recipients.
    Feller ED, Sorensen EN, Haddad M, Pierson RN, Johnson FL, Brown JM, Griffith BP.
    Ann Thorac Surg; 2007 Mar 24; 83(3):1082-8. PubMed ID: 17307463
    [Abstract] [Full Text] [Related]

  • 16. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group.
    N Engl J Med; 2001 Nov 15; 345(20):1435-43. PubMed ID: 11794191
    [Abstract] [Full Text] [Related]

  • 17. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients.
    Teuteberg JJ, Ewald GA, Adamson RM, Lietz K, Miller LW, Tatooles AJ, Kormos RL, Sundareswaran KS, Farrar DJ, Rogers JG.
    J Am Coll Cardiol; 2012 Jul 03; 60(1):44-51. PubMed ID: 22541834
    [Abstract] [Full Text] [Related]

  • 18. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA, Lodge AJ, Blue LJ, Smith PK, Felker GM, Hernandez AF, Rosenberg PB, Rogers JG.
    N C Med J; 2006 Jul 03; 67(2):110-5. PubMed ID: 16752713
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.
    Dang NC, Topkara VK, Kim BT, Mercando ML, Kay J, Naka Y.
    J Thorac Cardiovasc Surg; 2005 Nov 03; 130(5):1302-9. PubMed ID: 16256782
    [Abstract] [Full Text] [Related]

  • 20. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S, Stypmann J, Welp H, Schmid C, Drees G, Rukosujew A, Scheld HH.
    Ann Thorac Surg; 2006 Nov 03; 82(5):1774-8. PubMed ID: 17062246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.